170688 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes Isomerases (5.)
Sub-classes:USE OF PGAM2 IN BREEDING OF BLCATTLE BLACK CATTLE
#2MOLECULAR PROFILING OF TUMORS
#3FKBP52-DERIVED THERAPEUTIC PEPTIDES THAT INHIBIT PATHOLOGICAL TAU AGGREGATION FOR THERAPEUTIC PURPOSES
#4MOLECULAR PROFILING OF TUMORS
#5BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF
#6METHOD OF CHARACTERISING POLYPEPTIDES USING A NANOPORE
#7BIOMARKER PANEL FOR DIAGNOSIS OR PREDICTION OF BRAIN METASTASIS OF LUNG CANCER, AND USE THEREOF
#8Supermere Nanoparticles and Methods of Isolation and Use Thereof
#9SYSTEMS AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES
#10METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#11SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#12PROTEOMIC SAMPLE INVESTIGATION METHOD FOR DIAGNOSING RHABDOMYOLYSIS AND KITS FOR IMPLEMENTING SAME
#13MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#14Anti-Tetranor-PGDM Monoclonal Antibody and Use Thereof
#15PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
#16COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT
#17AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER
#18BIOMARKER COMPOSITION FOR DIAGNOSING DEGENERATIVE BRAIN DISEASES
#19LABELS COMPRISING DIBROMOPYRIDAZINEDIONES FOR IMMUNOASSAYS AND METHODS OF PRODUCTION AND USE THEREOF
#20INHIBITION OF FKBP1A FOR THE TREATMENT OF TRIPLE-NEGATIVE MAMMARY CARCINOMA
#21MOLECULAR PROFILING OF TUMORS
#22PREECLAMPSIA BIOMARKERS AND USE THEREOF
#23A COMPOUND FOR THE DETERMINATION OF THE PROTEIN FKBP12 AND A SENSOR UNIT COMPRISING IT
#24BIOMARKER
#25Semi-quantitative lateral-flow immunoassay for the detection of CSF leaks
#26Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer
#27MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#28METHODS OF INHIBITING PROLIFERATIVE CELLS
#29Protein biomarkers for diseases associated with the contact activation system
#30DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
#31COMPOSITIONS AND METHODS FOR PROTEIN DETECTION
#32METHOD FOR SCREENING AGENTS PROMOTING SKIN BARRIER FUNCTION AND METHOD FOR EVALUATING SKIN BARRIER FUNCTION TAKING EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL AS INDICATOR
#33METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#34MOLECULAR PROFILING FOR CANCER
#35METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF CONFORMATION-SPECIFIC ANTIBODIES
#36METHODS FOR DIAGNOSING AND ASSESSING TREATMENT FOR CUSHING'S SYNDROME
#37FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#38NON-INVASIVE ENZYME SCREEN FOR TISSUE REMODELLING-ASSOCIATED CONDITIONS
#39Semi-quantitative lateral-flow immunoassay for the detection of CSF leaks
#40Compositions and methods for treating multiple myeloma
#41NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY
#42MOLECULAR PROFILING OF TUMORS
#43Amino acid sequence presenting fusion polypeptide and its use
#44Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#45PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#46METHOD OF SELECTIVELY INHIBITING MPGES-1
#47Ultrapurified DsbA and DsbC and methods of making and using the same
#48NON-INVASIVE ENZYME SCREEN FOR TISSUE REMODELLING-ASSOCIATED CONDITIONS
#49Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
#50Methods for diagnosing and assessing treatment for Cushing's syndrome
#51Prostate cancer-associated secreted proteins
#52FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#53METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#54Methods for treating Cushing's syndrome
#55METHOD FOR PREDICTING AND EVALUATING RESPONSIVENESS TO CANCER TREATMENT WITH DNA-DAMAGING CHEMOTHERAPEUTIC AGENTS
#56METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF CONFORMATION-SPECIFIC ANTIBODIES
#57MOLECULAR PROFILING FOR CANCER
#58Non-invasive biomarker to identify subject at risk of preterm delivery
#59PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#60PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORS
#61Compositions and methods for treating malignancies
#62Method for evaluating condition of skin dryness
#63METHODS (AMACR)
#64Identification of cancer protein biomarkers using proteomic techniques
#65ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1
#66Electrochemical sensor for analyte detection
#67Alpha methylacyl a coenzyme racemase detection
#68Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#69FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction
#70Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes
#71ISOLATION AND DETECTION OF CANCER CELLS
#72Biomarkers associated with schizophrenia
#73METHODS AND MATERIALS FOR ASSESSING ENZYME-NUCLEIC ACID COMPLEXES
#74Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
#75Ultrapurified DsbA and DsbC and methods of making and using the same
#76Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
#77Protein biomarker panels for detecting colorectal cancer and advanced adenoma
#78Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT
#79MOLECULAR PROFILING OF TUMORS
#80ASSAY METHODS FOR THE DETERMINATION OF FKBPL EXPRESSION LEVEL IN THE CONTEXT OF BREAST CANCER
#81METHOD OF INHIBITING BINDING OR ACTIVITY OF MIF BY ADMINISTERING A MIF ANTAGONIST
#82Amino acid sequence presenting fusion polypeptide and its use
#83Antibody specifically binding to insulin-like growth factor-1
#84In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells
#85Method of treating cancer that overexpresses TopBP1
#86TREATMENT OF CANCER
#87Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#88ANTI-MIF ANTIBODY CELL MIGRATION ASSAY
#89IDENTIFICATION AND ERADICATION OF INSECT PESTS
#90Antibody cocktail
#91Method for testing for cardiovascular disease with cyclophilin A
#92Non-invasive biomarker to identify subject at risk of preterm delivery
#93Predictive marker for topoisomerase I inhibitors
#94Composition for preventing hair loss or enhancing hair growth comprising cyclophilin A
#95Method for predicting efficacy of c-Met inhibitor
#96Detection method of mammary gland disease
#97CANCER PROGNOSTIC ASSAYS
#98MRM-MS SIGNATURE ASSAY
#99Methods and compositions for the generation and use of conformation-specific antibodies
#100Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#101Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agents
#102Process for detection of alzheimer's disease from a serum sample
#103Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#104Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer
#105Oxidosqualene cyclase as a protein target for anticancer therapeutics
#106Methods and compositions for topoisomerase I modulated tumor suppression
#107DDX3 as a biomarker for cancer and methods related thereto
#108TOP2A inhibition by temozolomide and its predictive value of GBM patients survival
#109Methods and compositions for the generation and use of conformation-specific antibodies
#110FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#111RECQL4/RECQL4 VARIANT-P53 COMPLEX FOR ALTERED MITOCHONDRIAL FUNCTION IN ROTHMUND-THOMSON SYNDROME
#112Test method for male fertility by detecting a mutation in the PGAM4 gene
#113Assay methods for the determination of FKBPL expression level in the context of breast cancer
#114Antibody cocktail
#115IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#116Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#117MIF antagonists
#118LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE AS A BIOMARKER FOR LUNG CANCER PROGRESSION AND PROGNOSIS
#119Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
#120Microfluidic device screening method
#121Methods and compositions for topoisomerase I modulated tumor suppression
#122DIAGNOSIS OF SYSTEMIC DISEASES
#123Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer
#124Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#125Identifying organ damage
#126METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
#127Predictive marker for topoisomerase I inhibitors
#128Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#129METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
#130Identification of cancer protein biomarkers using proteomic techniques
#131Molecular profiling of tumors
#132CYCLOPHILIN D-AMYLOID BETA INTERACTION POTENTIATES MITOCHONDRIAL DYSFUNCTION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE
#133IDENTIFICATION AND CHARACTERIZATION OF RACEMASES, DEFINITION OF PROTEIN SIGNATURES, AND A TEST FOR DETECTING D-AMINO ACID AND FOR SCREENING MOLECULES CAPABLE OF INHIBITING THE ACTIVITY OF RACEMASE, ESPECIALLY PROLINE RACEMASE
#134Apoptosis inducer for cancer cell
#135TUMOR ANTIGEN PEPTIDE DERIVED FROM AMACR
#136Modulators of lanosterol synthetase for treating acne or hyperseborrhea
#137Mouse model and treatment of hereditary inclusion body myopathy
#138Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#139Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#140Pin1 as a marker for abnormal cell growth
#141NON-INVASIVE ENZYME SCREEN FOR TISSUE REMODELLING-ASSOCIATED CONDITIONS
#142SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF
#143Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#144Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers
#145Assay
#146Method of Detecting or Differentiating Rheumatoid Arthritis and Method of Determining Stage of Disease or Degree of Dysfunction with Regard to Rheumatoid Arthritis
#147Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
#148METHOD FOR DIAGNOSING CANCER OF THE PROSTATE
#149Methods and Composition for Diagnosing and Treating Cancer
#150Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#151Biomarker for gestational trophoblastic disease
#152Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases
#153Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of
#154ALPHA METHYLACYL A COENZYME RACEMASE DETECTION
#155Apoptosis Inducer for Cancer Cell
#156Method and kits for detecting cerebrospinal fluid in a sample
#157Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#158Tissue diagnostics for ovarian cancer
#159Non-invasive enzyme screen for tissue remodeling associated conditions
#160Methods and compositions for modulating somatolactogenic functions
#161Methods and kits for detecting cerebrospinal fluid in a sample
#162Gene causative of Rothmund-Thomson syndrome and gene product
#163Gene causative of Rothmund-Thomson syndrome and its gene product
#164Method of screening for agents that modulate a homer signaling pathway
#165Werner's syndrome helicase as a target for anti -HIV/AIDS therapy
#166Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
#167Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase
#168Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
#169Use of Pin1 inhibitors for treatment of cancer
#170Identification of cancer protein biomarkers using proteomic techniques
#171Manipulation of RNA interference through modulation of armitage activity
#172Plant protein disulfide isomerase
#173Pin1 as a marker for abnormal cell growth
#174Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
#175Secreted and transmembrane polypeptides and nucleic acids encoding the same
#176Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof
#177Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
#178Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use